Evidence mapPaperPMID 41013410Full record

ArticleBMC medical informatics and decision making2025

Developing an interpretable machine learning model for easily detecting insulin resistance among breast cancer survivors: a cross-sectional study.

Mengxia Fu, Zhiming Peng, Xue Yu, Dapeng Lv, Min Wu

Erratum issuedAbstract read
In one paragraph

Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Mengxia Fu *Galactophore Department, Galactophore Center, Beijing Shijitan Hospital, Capital Medical University, Tieyi Road 10, Beijing, 100038, China. fmx3973@bjsjth.cn.
Zhiming Peng *Department of Orthopedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xue Yu *Department of Breast Surgery, Peking University International Hospital, Life Park Road No.1 Life Science Park, Beijing, 102206, China.
Dapeng LvGalactophore Department, Galactophore Center, Beijing Shijitan Hospital, Capital Medical University, Tieyi Road 10, Beijing, 100038, China.
Min WuGalactophore Department, Galactophore Center, Beijing Shijitan Hospital, Capital Medical University, Tieyi Road 10, Beijing, 100038, China. wumin3736@bjsjth.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo develop and validate a classification model for insulin resistance in female individuals who have survived breast cancer using easily obtainable clinical and demographic features.

methodsData were obtained from the U.S. National Health and Nutrition Examination Survey (NHANES) spanning 1999 to March 2020. A total of 340 female individuals who have survived breast cancer were included, and participants were randomly assigned to a training set (n = 239) and a testing set (n = 101). Multiple machine learning algorithms were trained, including Logistic Regression, Random Forest, and Support Vector Machine. Model performance was evaluated using area under the receiver operating characteristic curve (AUC) and decision curve analysis (DCA).

resultsAll models demonstrated strong classification performance in the testing set, with AUC values exceeding 0.87. Among them, the Random Forest and Support Vector Machine models showed superior performance in DCA. Of the seven input features-body mass index, fasting blood glucose, triglyceride, HDL cholesterol, poverty income ratio, race, and education-fasting blood glucose had the highest positive feature importance for classifying insulin resistance.

conclusionsThis study demonstrates the feasibility of using machine learning algorithms to accurately predict insulin resistance in individuals who have survived breast cancer with a limited set of clinical and demographic variables. The Random Forest and Support Vector Machine models, in particular, offer strong classification performance and may support clinicians in early identification and management of insulin resistance among individuals in this high-risk population.

Indexed as

Breast NeoplasmsCancer SurvivorsInsulin ResistanceMachine LearningAdultAgedCross-Sectional StudiesFemaleHumansMiddle AgedNutrition Surveys

Identifiers

PMID41013410
PMCPMC12465519

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.